Kennedy Capital Management’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-22,211
| Closed | -$1.83M | – | 698 |
|
|
2023
Q2 | $1.83M | Buy |
22,211
+2,528
| +13% | +$208K | 0.04% | 479 |
|
|
2023
Q1 | $2.02M | Buy |
19,683
+2,124
| +12% | +$218K | 0.06% | 406 |
|
|
2022
Q4 | $2.57M | Buy |
17,559
+4,621
| +36% | +$677K | 0.07% | 386 |
|
|
2022
Q3 | $2.19M | Buy |
12,938
+9,402
| +266% | +$1.59M | 0.06% | 403 |
|
|
2022
Q2 | $408K | Buy |
+3,536
| New | +$408K | 0.01% | 556 |
|